Back
Results - Announcements
Sales rise 16.29% to Rs 705.36 crore
Epigral consolidated net profit declines 37.93% in the June 2026 quarter
27-Jul-2026, 05:58
Net profit of Epigral declined 37.93% to Rs 99.74 crore in the quarter ended June 2026 as against Rs 160.69 crore during the previous quarter ended June 2025. Sales rose 16.29% to Rs 705.36 crore in the quarter ended June 2026 as against Rs 606.54 crore during the previous quarter ended June 2025.
Net profit of Epigral declined 37.93% to Rs 99.74 crore in the quarter ended June 2026 as against Rs 160.69 crore during the previous quarter ended June 2025. Sales rose 16.29% to Rs 705.36 crore in the quarter ended June 2026 as against Rs 606.54 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 705.36 | 606.54 | 16 |
| OPM % | 25.41 | 26.94 | - |
| PBDT | 176.64 | 148.55 | 19 |
| PBT | 133.74 | 107.01 | 25 |
| NP | 99.74 | 160.69 | -38 |
Powered by Capital Market - Live News